Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
We review 2024 tax-efficient index fund options and provide practical guidance for incorporating them into a retirement strategy.
24,809 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Bitcoin surged toward $71k and then cooled near $70k as geopolitical headlines about Iran dominated market sentiment,...
New documents reveal Epstein used elite ties to influence major philanthropy groups, raising questions about governan...
IBM rallied today on a blend of solid earnings, growing cloud demand, and quantum computing momentum backed by govern...
As AI use expands from training to real-world deployment, memory players like Micron face a pivotal moment. This arti...
For years, SK Hynix has traded at a discount to Micron. This article explains why the gap exists, what could close it...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
A late-2025 market study shows home equity decreases nationally in Q4, signaling a cool-down after a sizzling run for...
A proposed state ban on institutional buyers could change how Californians get loans for homes and how lenders price ...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
A seismic shift in how the Fed communicates could redefine market expectations. This piece examines kevin warsh shift...
As the Fed hints at slower rate moves, crypto markets stir. This guide explains what the federal reserve signals good...